Velavigo Closes $60 Million Pre-A+ Financing Round to Advance Global Clinical Trials
Velavigo, a Shanghai-based pharmaceutical startup, has reportedly secured USD 60 million in a Pre-A+ financing...
VelaVigo
Velavigo and Ollin Biosciences Ink licensing Deal for First-in-Class BsAb VBS-102
Velavigo, a biotech company with operations in Shanghai, China, and Boston, USA, has entered into...
VelaVigo and Avenzo Therapeutics Ink Global Partnership for Nectin4/TROP2 Bispecific ADC
Shanghai-based biotech company VelaVigo, specializing in bispecific/multi-specific antibodies and antibody drug conjugates (ADCs), has announced...